It does bode well for the long term company prospects.
I wouldn't necessarily relate the pivot a few days ago to this announcement though.
The pivot was on next to no volume. Secondly the pivot was after the gap between option conversion and heads was almost unprofitable, so it was never going to fall further based on the options expiring alone and was always a very good chance to bounce.
Fantastic news, gives option holders some relief and every chance of bolstering the PTX coffers for moving on to this next exciting phase.
I can't speak for the remainder of March with the option expiry due, but I'm quietly excited for the remainder of 2023 and in particular the back end as OmniCar potentially hits veins.
- Forums
- ASX - By Stock
- PTX
- Ann: FDA grants broader orphan drug status to PTX100 for TCLs
Ann: FDA grants broader orphan drug status to PTX100 for TCLs, page-10
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.40M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $16.31K | 421.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47849 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 73928 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47849 | 0.039 |
5 | 707297 | 0.038 |
8 | 387500 | 0.037 |
5 | 708916 | 0.036 |
3 | 253590 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 73928 | 2 |
0.041 | 200000 | 2 |
0.042 | 499154 | 4 |
0.043 | 449950 | 2 |
0.045 | 217151 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |